We are live on
!
Find out more
Boston Trust Walden Portfolio holdings
AUM
$13.1B
Turnover
6.42%
1-Year Est. Return
24.63%
This Fund
S&P 500
This Quarter
Est. Return
+3.74%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.29%
AUM
$6.22B
AUM Growth
-$194M
(-3%)
Cap. Flow
-$367M
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
16.53%
Holding
380
New
29
Increased
159
Reduced
150
Closed
10
Avg Time Held
2.8
years
Top 10 Avg Time Held
1.2
years
Top 20 Avg Time Held
2.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$18M |
| 2 |
Monro
MNRO
|
+$15.1M |
| 3 |
Dentsply Sirona
XRAY
|
+$14.8M |
| 4 |
Hubbell
HUBB
|
+$12.1M |
| 5 |
Northern Trust
NTRS
|
+$8.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$31.3M |
| 2 |
W.W. Grainger
GWW
|
+$26.8M |
| 3 |
Verizon
VZ
|
+$21.9M |
| 4 |
IPG Photonics
IPGP
|
+$18.2M |
| 5 |
Coherent Inc
COHR
|
+$16.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.36% |
| 2 | Healthcare | 17.82% |
| 3 | Technology | 14.53% |
| 4 | Industrials | 13.36% |
| 5 | Consumer Discretionary | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Vanguard Total World Stock ETF
VT
$81.8B
| $328K | 0.01% |
+4,850
| New | +$324K |
2017 Q2
0 quarters
|
|
352
Analog Devices
ADI
$197B
| $324K | 0.01% |
4,164
| – | – |
2016 Q4
2 quarters
|
|
353
DELISTED
Patterson Companies, Inc.
PDCO
| $324K | 0.01% |
6,899
| – | – |
2013 Q2
16 quarters
|
|
354
Estee Lauder
EL
$38.7B
| $306K | ﹤0.01% |
+3,192
| New | +$293K |
2017 Q2
0 quarters
|
|
355
Vertex Pharmaceuticals
VRTX
$128B
| $297K | ﹤0.01% |
+2,308
| New | +$278K |
2017 Q2
0 quarters
|
|
356
iShares Russell Mid-Cap ETF
IWR
$56.4B
| $287K | ﹤0.01% |
+5,980
| New | +$284K |
2017 Q2
0 quarters
|
|
357
Microchip Technology
MCHP
$41B
| $270K | ﹤0.01% |
+7,000
| New | +$275K |
2017 Q2
0 quarters
|
|
358
Henry Schein
HSIC
$9.69B
| $261K | ﹤0.01% |
3,634
| – | – |
2013 Q2
16 quarters
|
|
359
The Kraft Heinz Company
KHC
$27.9B
| $261K | ﹤0.01% |
3,050
| – | – |
2016 Q2
4 quarters
|
|
360
J.M. Smucker
SJM
$13.6B
| $255K | ﹤0.01% |
+2,156
| New | +$272K |
2017 Q2
0 quarters
|
|
361
McKesson
MCK
$117B
| $243K | ﹤0.01% |
1,476
| – | – |
2013 Q3
15 quarters
|
|
362
Baxter International
BAX
$13.3B
| $242K | ﹤0.01% |
3,990
| – | – |
2017 Q1
1 quarter
|
|
363
Gilead Sciences
GILD
$194B
| $240K | ﹤0.01% |
+3,395
| New | +$226K |
2017 Q2
0 quarters
|
|
364
Zoetis
ZTS
$32.6B
| $237K | ﹤0.01% |
+3,800
| New | +$224K |
2017 Q2
0 quarters
|
|
365
Bank of New York Mellon
BNY
$97.8B
| $234K | ﹤0.01% |
4,587
-50
| -1% | -$2.39K |
2017 Q1
1 quarter
|
|
366
Agilent Technologies
A
$49B
| $229K | ﹤0.01% |
3,862
| – | – |
2017 Q1
1 quarter
|
|
367
Travelers Companies
TRV
$80.9B
| $227K | ﹤0.01% |
+1,795
| New | +$221K |
2017 Q2
0 quarters
|
|
368
Hartford Financial Services
HIG
$36.4B
| $217K | ﹤0.01% |
+4,129
| New | +$205K |
2017 Q2
0 quarters
|
|
369
DELISTED
Brookline Bancorp
BRKL
| $146K | ﹤0.01% |
10,000
| – | – |
2016 Q2
4 quarters
|
|
|
SVU
370
DELISTED
SUPERVALU Inc.
SVU
| $132K | ﹤0.01% |
5,714
-2,479
| -30% | -$66K |
2015 Q2
8 quarters
|
|
371
Adient
ADNT
$1.42B
| – | – |
-3,007
| Closed | -$219K | – |
|
372
DELISTED
Coterra Energy
CTRA
| – | – |
-65,275
| Closed | -$1.56M | – |
|
373
DHI Group
DHX
$213M
| – | – |
-1,589,173
| Closed | -$6.28M | – |
|
374
DELISTED
Chart Industries
GTLS
| – | – |
-318,845
| Closed | -$11.1M | – |
|
375
Trustmark
TRMK
$2.62B
| – | – |
-388,122
| Closed | -$12.3M | – |
|
Similar funds
Boston Trust Walden's Q2 2017 Portfolio in Review
As of Q2 2017, Boston Trust Walden held 380 positions worth $6.22B, down 3% from $6.42B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Boston Trust Walden withdrew a net $367M in Q2 2017, closing 10 positions and reducing 150 holdings. Its most notable exit was Air Methods Corp, an estimated $15.4M position sold in full.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.
Against the trend, Boston Trust Walden opened a new position in Monro worth $12.7M.
- Boston Trust Walden's largest Q2 2017 buy was Monro: 303,868 shares worth $12.7M.
- Boston Trust Walden added most to Alphabet (Google) Class C in Q2 2017, an estimated $18M increase.
- Boston Trust Walden's biggest Q2 2017 reduction was CR Bard Inc., cutting an estimated $31.3M.
- Boston Trust Walden fully exited Air Methods Corp in Q2 2017, selling an estimated $15.4M.
- Boston Trust Walden's ten largest holdings make up 17% of its $6.22B portfolio in Q2 2017.
- Boston Trust Walden opened 29 new positions and closed 10 in Q2 2017.
- Boston Trust Walden's portfolio value fell 3% quarter-over-quarter to $6.22B.
Based on Boston Trust Walden's 13F filing for Q2 2017, filed 19 Jul 2017.